Apremilast News

← Back to News Overview


Apremilast currently has 3 news articles, with 10 predicted indications.

This page combines the AI-predicted indications for Apremilast with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
  • Predicted indications (10):
    • migraine disorder (98.7%)
    • migraine with brainstem aura (98.5%)
    • rheumatoid arthritis (98.1%)📰 RA
    • pulmonary hypertension (98.1%)
    • migraine with or without aura, susceptibility to (97.8%)
    • kyphoscoliotic heart disease (97.8%)
    • brachydactyly-syndactyly syndrome (97.4%)
    • colobomatous microphthalmia-rhizomelic dysplasia syndrome (97.0%)
    • atrophoderma vermiculata (96.7%)
    • ulerythema ophryogenesis (96.2%)

View full drug report →

Infections at birth substantially increase the risk of autism and intellectual disability, study finds

2026-09-28 RA

Source: CIDRAP


Xella Health Builds Women’s Precision Health Operating System

2026-09-28 RA

Source: Forbes


WHO Sets 2027 Southern Hemisphere Flu Vaccine Formula as Viruses Shape Risks

2026-09-28 RA

Source: Devdiscourse


Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.

Copyright © 2026 藥提醒科技有限公司 (yao.care). For research purposes only. Not medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.